570 related articles for article (PubMed ID: 1370705)
21. Characterization of [3H]substance P binding sites in human skin.
Bianchi B; Matucci R; Danesi A; Rossi R; Ipponi P; Giannotti B; Johansson O; Cappugi P
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):6-10. PubMed ID: 10188142
[TBL] [Abstract][Full Text] [Related]
22. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
Strigas J; Burcher E
Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
[TBL] [Abstract][Full Text] [Related]
23. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; MartÃn JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
24. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
25. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
26. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
27. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
28. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
29. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
30. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.
Beaujouan JC; Torrens Y; Saffroy M; Glowinski J
Neuroscience; 1986 Aug; 18(4):857-75. PubMed ID: 2429231
[TBL] [Abstract][Full Text] [Related]
31. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
Rigby M; O'Donnell R; Rupniak NM
J Comp Neurol; 2005 Oct; 490(4):335-53. PubMed ID: 16127708
[TBL] [Abstract][Full Text] [Related]
32. Radioligand binding, autoradiographic and functional studies demonstrate tachykinin NK-2 receptors in dog urinary bladder.
Mussap CJ; Stamatakos C; Burcher E
J Pharmacol Exp Ther; 1996 Oct; 279(1):423-34. PubMed ID: 8859022
[TBL] [Abstract][Full Text] [Related]
33. Radioligand binding and functional characterisation of tachykinin receptors in chicken small intestine.
Liu L; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):305-13. PubMed ID: 11683517
[TBL] [Abstract][Full Text] [Related]
34. Binding sites for [125I]-Bolton-Hunter scyliorhinin II in guinea-pig ileum: a radioligand binding, functional and autoradiographic study.
Mussap CJ; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):301-9. PubMed ID: 7824047
[TBL] [Abstract][Full Text] [Related]
35. The presence of NK3 tachykinin receptors on rat uterus.
Barr AJ; Watson SP; Bernal AL; Nimmo AJ
Eur J Pharmacol; 1991 Oct; 203(2):287-90. PubMed ID: 1724757
[TBL] [Abstract][Full Text] [Related]
36. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
Gether U; Johansen TE; Schwartz TW
J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
Guard S; Watson SP; Maggio JE; Too HP; Watling KJ
Br J Pharmacol; 1990 Apr; 99(4):767-73. PubMed ID: 1694464
[TBL] [Abstract][Full Text] [Related]
38. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
[TBL] [Abstract][Full Text] [Related]
39. The rat submaxillary gland contains predominantly P-type tachykinin binding sites.
Buck SH; Burcher E
Peptides; 1985; 6(6):1079-84. PubMed ID: 2422632
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterisation of two tachykinin binding sites in the rat cerebral cortex.
Torrens Y; Beaujouan JC; Glowinski J
Neuropeptides; 1985 Mar; 6(1):59-70. PubMed ID: 2581167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
